Previous 10 | Next 10 |
2023-04-20 17:51:34 ET Gainers: ContextLogic ( WISH ) +28% . EyePoint Pharmaceuticals ( EYPT ) +7% . Caribou Biosciences ( CRBU ) +5% . Ocular Therapeutix ( OCUL ) +3% . Coherus BioSciences ( CHRS ) +3% . Losers: CRISPR T...
2023-04-18 18:07:54 ET Summary The singularity is not here yet, but it will arrive very soon. The economic impact of the singularity may be devastating unless governments and central banks do something about it. Nothing is currently being done to prepare for the arrival of the...
2023-04-18 05:30:00 ET You don't have to start out with thousands of dollars to grow your wealth in the stock market. In fact, with just $100, you can buy shares of companies that can boost your portfolio over time. Plenty of healthcare players offer you this opportunity right now. Let'...
2023-04-17 16:05:00 ET Shares of CRISPR Therapeutics (NASDAQ: CRSP) are enjoying another strong session Monday. Specifically, the gene-editing company's stock was up by a healthy 7.26% on exceptionally heavy volume as of 2:02 p.m. ET Monday afternoon. CRISPR's shares have been s...
2023-04-17 14:50:38 ET Shares of clinical-stage biotech Editas Medicine (NASDAQ: EDIT) rose as much as 14% on Monday, lifted by a trend over the past couple of days favoring gene-editing stocks. Editas stock also benefited from the news last week that the company was appointing ...
2023-04-16 05:30:00 ET If you're looking to add some growth to your portfolio, you may find it in biotech stocks. Two in particular offer investors a terrific opportunity right now. That's because both of them are in the early stages of their growth story. And this means early investors cou...
2023-04-14 10:45:01 ET Summary ICER identifies a justifiable price point of up to $1.9 million for upcoming sickle cell disease treatments, Exa-cel and Lovo-cel. The ICER report offers valuable insights into the economic benefits, pricing ranges and eligible population for these g...
2023-04-13 18:35:19 ET Fueled by cooler-than-expected wholesale inflation statistics, stocks pushed higher on Thursday, led by a nearly 2% rise in the Nasdaq. The S&P 500 climbed 1.3%. CRISPR Therapeutics ( NASDAQ: CRSP ) represented one of the day's standout gainers, postin...
ZUG, Switzerland and CAMBRIDGE, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to parti...
2023-04-13 15:59:42 ET Shares of gene editing companies rose Thursday as Wall Street took notice of the underperforming subsector issuing a series of bullish views despite the recent selloff. Notable gainers include Editas Medicine ( NASDAQ: EDIT ), Sangamo Therapeutics ( SG...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website: